These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of psoriasis: role of calcipotriene. Kirsner RS, Federman D. Am Fam Physician; 1995 Jul; 52(1):237-40, 243-4. PubMed ID: 7604767 [Abstract] [Full Text] [Related]
3. New developments in topical sequential therapy for psoriasis. Koo JY. Skin Therapy Lett; 2005 Nov; 10(9):1-4. PubMed ID: 16292458 [Abstract] [Full Text] [Related]
4. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization. Bovenschen HJ, Erceg A, Van Vlijmen-Willems I, Van De Kerkhof PC, Seyger MM. J Dermatolog Treat; 2007 Nov; 18(1):32-9. PubMed ID: 17365265 [Abstract] [Full Text] [Related]
5. Calcipotriene/betamethasone in the treatment of psoriasis: a review article. Saraceno R, Gramiccia T, Frascione P, Chimenti S. Expert Opin Pharmacother; 2009 Oct; 10(14):2357-65. PubMed ID: 19663634 [Abstract] [Full Text] [Related]
7. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies. Lebwohl M, Menter A, Weiss J, Clark SD, Flores J, Powers J, Balin AK, Kempers S, Glinert RJ, Fleming T, Liu Y, Graeber M, Pariser DM. J Drugs Dermatol; 2007 Apr; 6(4):428-35. PubMed ID: 17668541 [Abstract] [Full Text] [Related]
8. Apoptosis, P53 and Bcl-2 expression in response to topical calcipotriol therapy for psoriasis. El-Domyati M, Barakat M, Abdel-Razek R, El-Din Anbar T. Int J Dermatol; 2007 May; 46(5):468-74. PubMed ID: 17472673 [Abstract] [Full Text] [Related]
13. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis. Menter A, Abramovits W, Colón LE, Johnson LA, Gottschalk RW. J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896 [Abstract] [Full Text] [Related]
15. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis. Zhu X, Wang B, Zhao G, Gu J, Chen Z, Briantais P, Andres P. J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):466-72. PubMed ID: 17373972 [Abstract] [Full Text] [Related]
16. Microcirculatory modifications of psoriatic lesions during topical therapy. Rosina P, Giovannini A, Gisondi P, Girolomoni G. Skin Res Technol; 2009 May; 15(2):135-8. PubMed ID: 19622121 [Abstract] [Full Text] [Related]
19. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial. Jemec GB, Ganslandt C, Ortonne JP, Poulin Y, Burden AD, de Unamuno P, Berne B, Figueiredo A, Austad J. J Am Acad Dermatol; 2008 Sep; 59(3):455-63. PubMed ID: 18694678 [Abstract] [Full Text] [Related]